Friday, February 12, 2016 Last update: 10:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Generex Biotechnology Corporation

News articles for Generex Biotechnology Corporation:

Thursday, October 15, 2015

Tuesday, October 13, 2015

  • Generex Announces Agreement to Acquire Equity Interest in MediTemp Ltd.
    WORCESTER, Mass. and TORONTO, Oct. 13, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with MediTemp Ltd. (MediTemp) (www.meditemp-varicure.com), a private Israeli company that has developed a proprietary cooling technology designed to ... read more

Tuesday, October 6, 2015

  • Generex Announces Agreement to Acquire Equity Interest in Alfa Rhythm Ltd.
    A unique opportunity for GNBT to expand the scope of its business WORCESTER, Mass. and TORONTO, Oct. 6, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that it has entered into a non-binding Letter of Intent (LOI) with Alfa Rhythm Ltd. (Alfa) (www.alfarhythm.com), a private Israeli company ... read more

Thursday, October 1, 2015

  • Generex Announces Issuance of Buccal Cannabis White Paper
    WORCESTER, Mass. and TORONTO, Oct. 1, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the use of cannabis for medicinal purposes and the joint venture between Generex and CannScience Innovations Inc. (www.cannsci.com) for the design and development ... read more

Wednesday, September 30, 2015

Tuesday, September 8, 2015

  • Generex Announces Commencement of Buccal Leuprolide R&D Work
    Collaboration with NHTherapeutics has begun WORCESTER, Mass. and TORONTO, Sept. 8, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) today announced that research and development work on buccal Leuprolide has begun. The Company previously announced a Memorandum of Understanding with NHTherapeutics, Inc. (www.nhtherapeutics.com) pursuant to which the ... read more

Wednesday, September 2, 2015

  • Generex Announces Formalization of Buccal Cannabis Co-Development Plan
    Contract signed with CannScience Innovations Inc. WORCESTER, Mass. and TORONTO, Sept. 2, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced that its previously announced intention to implement a buccal cannabis co-development arrangement with CannScience Innovations Inc. (www.cannsci.com) has been formalized. Generex and CannScience have entered into ... read more

Thursday, August 27, 2015

  • Generex Announces Issuance of Buccal Insulin White Paper
    Company Updates Stockholders on Generex Oral-lyn(TM) WORCESTER, Mass. and TORONTO, Aug. 27, 2015 /PRNewswire/ -- Generex Biotechnology Corporation (www.generex.com) (OTCQB: GNBT) today announced the issuance of a white paper on the status of Generex Oral-lyn(TM), the Company's proprietary buccal insulin spray product. The white paper was ... read more

Tuesday, August 25, 2015